leisure time -WSS

leisure time

author：leisure time 2025-09-30 00:03:19 - browse：4

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： What we need to know about Arena Bioworks

WSS

New Ultima Genomics DNA sequencer can read genome for $100

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

General Catalyst, Summa Health deal will turn on physician buy

Apple Vision Pro: A first look at health apps on the new VR headset

Commercial surrogacy can be ethical, despite pope’s claims

Videos point to link between seizures and unexplained toddler deaths

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Dobbs anniversary: the lost opportunity of abortion as health care

The biotech scorecard for Q1: 17 stock

Novavax promises a turnaround & Lilly roils the obesity market

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Guidelines to prevent youth baseball injuries need more muscle

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Jerome Adams on the need for new antivirals for Covid

Novo Nordisk to expand supply of Wegovy for U.S. patients

Trump demands the U.S. pay no more for drugs than other countries … again

Cybersecurity threat forces Lurie Children's to take systems offline

Wikipedia

Feng Zhang CRISPR delivery startup lays off quarter of staff

How a scoliosis diagnosis changed the life of one young dancer

New Ultima Genomics DNA sequencer can read genome for $100

Morgan Health, with ambitious aims, wants you to know it’s still here

Chronically ill young patients struggle to find fertility info

Juul spent big to court Black leaders to promote its e

knowledge

knowledge

hotspot

entertainment